ArticleJournal of cardiovascular development and disease2025

Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence.

Srikanth Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.